Our 3’UTR technology specifically targets and degrades any transcript of interest

Gallery

Contacts

411 University St, Seattle, USA

347-842-6873
339-368-0125
646-620-8700

News

How to Build a Next-gen MRNA Company to Combat Cancer

Event by Cure.

UTR Therapeutics CEO and genome engineer Dr. Chidiebere Awah joins Cure CEO Seema Kumar to explain the science and how he developed his company to deploy first–in–class mRNA overwriting therapies and what this means for a wide range of diseases and disorders.

Author

pwsadmin